122 related articles for article (PubMed ID: 17910636)
1. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
[TBL] [Abstract][Full Text] [Related]
2. Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.
Norén-Nyström U; Heyman M; Frisk P; Golovleva I; Sundström C; Porwit A; Roos G; Bergh A; Forestier E
Br J Haematol; 2009 Sep; 146(5):521-30. PubMed ID: 19594745
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
4. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p75 neurotrophin receptor in acute leukaemia.
Beutel G; Meyer J; Ma L; Yin S; Eder M; von Neuhoff N; Wilkens L; Wei J; Hertenstein B; Heil G; Schlegelberger B; Ganser A; Li Z; Baum C
Br J Haematol; 2005 Oct; 131(1):67-70. PubMed ID: 16173964
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow Th2 cytokine expression as predictor for relapse in childhood acute lymphoblastic leukemia (ALL).
Stachel D; Albert M; Meilbeck R; Kreutzer B; Haas RJ; Schmid I
Eur J Med Res; 2006 Mar; 11(3):102-13. PubMed ID: 16751110
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
10. In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia.
Schneider P; Costa O; Legrand E; Bigot D; Lecleire S; Grassi V; Vannier JP; Vasse M
Leuk Res; 2010 Jan; 34(1):24-31. PubMed ID: 19748669
[TBL] [Abstract][Full Text] [Related]
11. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
14. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
16. The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia.
De Moerloose B; Swerts K; Benoit Y; Laureys G; Loeys T; Philippé J; Dhooge C
Pediatr Hematol Oncol; 2003; 20(5):381-91. PubMed ID: 12775536
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of BCL-2 can distinguish small numbers of acute lymphoblastic leukaemia cells from B-cell precursors.
Hartung L; Bahler DW
Br J Haematol; 2004 Oct; 127(1):50-8. PubMed ID: 15384977
[TBL] [Abstract][Full Text] [Related]
18. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
19. CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.
Li XM; Zhang LP; Wang YZ; Lu AD; Chang Y; Zhu HH; Qin YZ; Lai YY; Kong Y; Huang XJ; Liu YR
Leuk Res; 2016 Apr; 43():33-8. PubMed ID: 26930456
[TBL] [Abstract][Full Text] [Related]
20. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]